APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Isoxazoline Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Isoxazoline Drugs Market Analysis and Forecast 2026-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchIsoxazoline Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Isoxazoline Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Isoxazoline Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isoxazoline Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Isoxazoline Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Isoxazoline Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Isoxazoline Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Isoxazoline Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Isoxazoline Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Isoxazoline Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Isoxazoline Drugs include Zoetis Inc, Nissan Chemical Corporation, Merck Animal Health Inc., Elanco Animal Health Incorporated and Boehringer Ingelheim International GmbH, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Isoxazoline Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Isoxazoline Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Isoxazoline Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Isoxazoline Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Isoxazoline Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Isoxazoline Drugs sales, projected growth trends, production technology, application and end-user industry.

Isoxazoline Drugs Segment by Company

Zoetis Inc

Nissan Chemical Corporation

Merck Animal Health Inc.

Elanco Animal Health Incorporated

Boehringer Ingelheim International GmbH

Isoxazoline Drugs Segment by Type

Sarolaner

Lotilaner

Fluralaner

Afoxolaner

Others

Isoxazoline Drugs Segment by Application

Dog

Cat

Others

Isoxazoline Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isoxazoline Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isoxazoline Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isoxazoline Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Isoxazoline Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Isoxazoline Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Isoxazoline Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Isoxazoline Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sarolaner Major Manufacturers Table 3. Lotilaner Major Manufacturers Table 4. Fluralaner Major Manufacturers Table 5. Afoxolaner Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Isoxazoline Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Dog Major Manufacturers Table 9. Cat Major Manufacturers Table 10. Others Major Manufacturers Table 11. Isoxazoline Drugs Industry Trends Table 12. Isoxazoline Drugs Industry Drivers Table 13. Isoxazoline Drugs Industry Opportunities and Challenges Table 14. Isoxazoline Drugs Industry Restraints Table 15. Global Isoxazoline Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Isoxazoline Drugs Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Isoxazoline Drugs Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Isoxazoline Drugs Revenue Market Share by Region (2021-2026) Table 19. Global Isoxazoline Drugs Revenue Market Share by Region (2027-2032) Table 20. Global Isoxazoline Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Isoxazoline Drugs Sales by Region (2021-2026) & (K Units) Table 22. Global Isoxazoline Drugs Sales by Region (2027-2032) & (K Units) Table 23. Global Isoxazoline Drugs Sales Market Share by Region (2021-2026) Table 24. Global Isoxazoline Drugs Sales Market Share by Region (2027-2032) Table 25. Global Isoxazoline Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Isoxazoline Drugs Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Isoxazoline Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Isoxazoline Drugs Sales Market Share by Manufacturers (2021-2026) Table 29. Global Isoxazoline Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Isoxazoline Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Isoxazoline Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Isoxazoline Drugs Manufacturers, Product Type & Application Table 33. Global Isoxazoline Drugs Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Isoxazoline Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Isoxazoline Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Isoxazoline Drugs Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Isoxazoline Drugs Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Isoxazoline Drugs Revenue Market Share by Type (2021-2026) Table 40. Global Isoxazoline Drugs Revenue Market Share by Type (2027-2032) Table 41. Global Isoxazoline Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 43. Global Isoxazoline Drugs Sales by Type (2027-2032) & (K Units) Table 44. Global Isoxazoline Drugs Sales Market Share by Type (2021-2026) Table 45. Global Isoxazoline Drugs Sales Market Share by Type (2027-2032) Table 46. Global Isoxazoline Drugs Price by Type (2021-2026) & (US$/Unit) Table 47. Global Isoxazoline Drugs Price by Type (2027-2032) & (US$/Unit) Table 48. Global Isoxazoline Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Isoxazoline Drugs Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Isoxazoline Drugs Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Isoxazoline Drugs Revenue Market Share by Application (2021-2026) Table 52. Global Isoxazoline Drugs Revenue Market Share by Application (2027-2032) Table 53. Global Isoxazoline Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 55. Global Isoxazoline Drugs Sales by Application (2027-2032) & (K Units) Table 56. Global Isoxazoline Drugs Sales Market Share by Application (2021-2026) Table 57. Global Isoxazoline Drugs Sales Market Share by Application (2027-2032) Table 58. Global Isoxazoline Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global Isoxazoline Drugs Price by Application (2027-2032) & (US$/Unit) Table 60. Zoetis Inc Company Information Table 61. Zoetis Inc Business Overview Table 62. Zoetis Inc Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Zoetis Inc Isoxazoline Drugs Product Portfolio Table 64. Zoetis Inc Recent Development Table 65. Nissan Chemical Corporation Company Information Table 66. Nissan Chemical Corporation Business Overview Table 67. Nissan Chemical Corporation Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Nissan Chemical Corporation Isoxazoline Drugs Product Portfolio Table 69. Nissan Chemical Corporation Recent Development Table 70. Merck Animal Health Inc. Company Information Table 71. Merck Animal Health Inc. Business Overview Table 72. Merck Animal Health Inc. Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Merck Animal Health Inc. Isoxazoline Drugs Product Portfolio Table 74. Merck Animal Health Inc. Recent Development Table 75. Elanco Animal Health Incorporated Company Information Table 76. Elanco Animal Health Incorporated Business Overview Table 77. Elanco Animal Health Incorporated Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Elanco Animal Health Incorporated Isoxazoline Drugs Product Portfolio Table 79. Elanco Animal Health Incorporated Recent Development Table 80. Boehringer Ingelheim International GmbH Company Information Table 81. Boehringer Ingelheim International GmbH Business Overview Table 82. Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Boehringer Ingelheim International GmbH Isoxazoline Drugs Product Portfolio Table 84. Boehringer Ingelheim International GmbH Recent Development Table 85. North America Isoxazoline Drugs Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Isoxazoline Drugs Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 88. North America Isoxazoline Drugs Sales by Type (2027-2032) & (K Units) Table 89. North America Isoxazoline Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 90. North America Isoxazoline Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 91. North America Isoxazoline Drugs Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Isoxazoline Drugs Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 94. North America Isoxazoline Drugs Sales by Application (2027-2032) & (K Units) Table 95. North America Isoxazoline Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 96. North America Isoxazoline Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 97. North America Isoxazoline Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America Isoxazoline Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 99. North America Isoxazoline Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 100. North America Isoxazoline Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 101. North America Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 102. North America Isoxazoline Drugs Sales by Country (2027-2032) & (K Units) Table 103. North America Isoxazoline Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 104. North America Isoxazoline Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 105. United States Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 106. Canada Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 107. Europe Isoxazoline Drugs Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Isoxazoline Drugs Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 110. Europe Isoxazoline Drugs Sales by Type (2027-2032) & (K Units) Table 111. Europe Isoxazoline Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 112. Europe Isoxazoline Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 113. Europe Isoxazoline Drugs Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe Isoxazoline Drugs Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 116. Europe Isoxazoline Drugs Sales by Application (2027-2032) & (K Units) Table 117. Europe Isoxazoline Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 118. Europe Isoxazoline Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 119. Europe Isoxazoline Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Isoxazoline Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. Europe Isoxazoline Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. Europe Isoxazoline Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 123. Europe Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 124. Europe Isoxazoline Drugs Sales by Country (2027-2032) & (K Units) Table 125. Europe Isoxazoline Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 126. Europe Isoxazoline Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 127. Germany Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 128. France Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 129. U.K. Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 130. Italy Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 132. China Isoxazoline Drugs Revenue by Type (2021-2026) & (US$ Million) Table 133. China Isoxazoline Drugs Revenue by Type (2027-2032) & (US$ Million) Table 134. China Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 135. China Isoxazoline Drugs Sales by Type (2027-2032) & (K Units) Table 136. China Isoxazoline Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 137. China Isoxazoline Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 138. China Isoxazoline Drugs Revenue by Application (2021-2026) & (US$ Million) Table 139. China Isoxazoline Drugs Revenue by Application (2027-2032) & (US$ Million) Table 140. China Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 141. China Isoxazoline Drugs Sales by Application (2027-2032) & (K Units) Table 142. China Isoxazoline Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 143. China Isoxazoline Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia Isoxazoline Drugs Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia Isoxazoline Drugs Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 147. Asia Isoxazoline Drugs Sales by Type (2027-2032) & (K Units) Table 148. Asia Isoxazoline Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 149. Asia Isoxazoline Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 150. Asia Isoxazoline Drugs Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Isoxazoline Drugs Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 153. Asia Isoxazoline Drugs Sales by Application (2027-2032) & (K Units) Table 154. Asia Isoxazoline Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 155. Asia Isoxazoline Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia Isoxazoline Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia Isoxazoline Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Asia Isoxazoline Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Asia Isoxazoline Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 160. Asia Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 161. Asia Isoxazoline Drugs Sales by Country (2027-2032) & (K Units) Table 162. Asia Isoxazoline Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 163. Asia Isoxazoline Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 164. Japan Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 165. South Korea Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 166. India Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 167. Australia Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 168. China Taiwan Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 169. Southeast Asia Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 170. SAMEA Isoxazoline Drugs Revenue by Type (2021-2026) & (US$ Million) Table 171. SAMEA Isoxazoline Drugs Revenue by Type (2027-2032) & (US$ Million) Table 172. SAMEA Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 173. SAMEA Isoxazoline Drugs Sales by Type (2027-2032) & (K Units) Table 174. SAMEA Isoxazoline Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 175. SAMEA Isoxazoline Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 176. SAMEA Isoxazoline Drugs Revenue by Application (2021-2026) & (US$ Million) Table 177. SAMEA Isoxazoline Drugs Revenue by Application (2027-2032) & (US$ Million) Table 178. SAMEA Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 179. SAMEA Isoxazoline Drugs Sales by Application (2027-2032) & (K Units) Table 180. SAMEA Isoxazoline Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 181. SAMEA Isoxazoline Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 182. SAMEA Isoxazoline Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. SAMEA Isoxazoline Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. SAMEA Isoxazoline Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. SAMEA Isoxazoline Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. SAMEA Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 187. SAMEA Isoxazoline Drugs Sales by Country (2027-2032) & (K Units) Table 188. SAMEA Isoxazoline Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 189. SAMEA Isoxazoline Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Brazil Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 191. Argentina Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 192. Chile Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 193. Colombia Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 194. Peru Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 195. Saudi Arabia Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 196. Israel Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 197. UAE Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 198. Turkey Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 199. Iran Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 200. Egypt Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Isoxazoline Drugs Distributors List Table 204. Isoxazoline Drugs Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Isoxazoline Drugs Image Figure 2. Global Isoxazoline Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isoxazoline Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sarolaner Image Figure 5. Lotilaner Image Figure 6. Fluralaner Image Figure 7. Afoxolaner Image Figure 8. Others Image Figure 9. Global Isoxazoline Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Isoxazoline Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Dog Image Figure 12. Cat Image Figure 13. Others Image Figure 14. Global Isoxazoline Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Figure 16. Global Isoxazoline Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Isoxazoline Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Isoxazoline Drugs Revenue Market Share by Region (2021-2032) Figure 19. Global Isoxazoline Drugs Sales (2021-2032) & (K Units) Figure 20. Global Isoxazoline Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Isoxazoline Drugs Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Isoxazoline Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Europe Isoxazoline Drugs Sales YoY (2021-2032) & (K Units) Figure 24. China Isoxazoline Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Isoxazoline Drugs Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Isoxazoline Drugs Sales YoY (2021-2032) & (K Units) Figure 27. Global Isoxazoline Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Isoxazoline Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Isoxazoline Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Isoxazoline Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Isoxazoline Drugs Revenue Market Share by Type (2021-2032) Figure 33. Global Isoxazoline Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Isoxazoline Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Isoxazoline Drugs Sales Market Share by Type (2021-2032) Figure 36. Global Isoxazoline Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Isoxazoline Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Isoxazoline Drugs Revenue Market Share by Application (2021-2032) Figure 39. Global Isoxazoline Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Isoxazoline Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Isoxazoline Drugs Sales Market Share by Application (2021-2032) Figure 42. North America Isoxazoline Drugs Revenue Share by Type (2021-2032) Figure 43. North America Isoxazoline Drugs Sales Share by Type (2021-2032) Figure 44. North America Isoxazoline Drugs Revenue Share by Application (2021-2032) Figure 45. North America Isoxazoline Drugs Sales Share by Application (2021-2032) Figure 46. North America Isoxazoline Drugs Revenue Share by Country (2021-2032) Figure 47. North America Isoxazoline Drugs Sales Share by Country (2021-2032) Figure 48. Europe Isoxazoline Drugs Revenue Share by Type (2021-2032) Figure 49. Europe Isoxazoline Drugs Sales Share by Type (2021-2032) Figure 50. Europe Isoxazoline Drugs Revenue Share by Application (2021-2032) Figure 51. Europe Isoxazoline Drugs Sales Share by Application (2021-2032) Figure 52. Europe Isoxazoline Drugs Revenue Share by Country (2021-2032) Figure 53. Europe Isoxazoline Drugs Sales Share by Country (2021-2032) Figure 54. China Isoxazoline Drugs Revenue Share by Type (2021-2032) Figure 55. China Isoxazoline Drugs Sales Share by Type (2021-2032) Figure 56. China Isoxazoline Drugs Revenue Share by Application (2021-2032) Figure 57. China Isoxazoline Drugs Sales Share by Application (2021-2032) Figure 58. Asia Isoxazoline Drugs Revenue Share by Type (2021-2032) Figure 59. Asia Isoxazoline Drugs Sales Share by Type (2021-2032) Figure 60. Asia Isoxazoline Drugs Revenue Share by Application (2021-2032) Figure 61. Asia Isoxazoline Drugs Sales Share by Application (2021-2032) Figure 62. Asia Isoxazoline Drugs Revenue Share by Country (2021-2032) Figure 63. Asia Isoxazoline Drugs Sales Share by Country (2021-2032) Figure 64. SAMEA Isoxazoline Drugs Revenue Share by Type (2021-2032) Figure 65. SAMEA Isoxazoline Drugs Sales Share by Type (2021-2032) Figure 66. SAMEA Isoxazoline Drugs Revenue Share by Application (2021-2032) Figure 67. SAMEA Isoxazoline Drugs Sales Share by Application (2021-2032) Figure 68. SAMEA Isoxazoline Drugs Revenue Share by Country (2021-2032) Figure 69. SAMEA Isoxazoline Drugs Sales Share by Country (2021-2032) Figure 70. Isoxazoline Drugs Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Isoxazoline Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Sarolaner
  • Lotilaner
  • Fluralaner
  • Afoxolaner
  • Others
Applications
  • Dog
  • Cat
  • Others
Companies covered
  • Zoetis Inc
  • Nissan Chemical Corporation
  • Merck Animal Health Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Isoxazoline Drugs Market by Type
  3. 1.2.1 Global Isoxazoline Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sarolaner
  5. 1.2.3 Lotilaner
  6. 1.2.4 Fluralaner
  7. 1.2.5 Afoxolaner
  8. 1.2.6 Others
  9. 1.3 Isoxazoline Drugs Market by Application
  10. 1.3.1 Global Isoxazoline Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Dog
  12. 1.3.3 Cat
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Isoxazoline Drugs Market Dynamics
  1. 2.1 Isoxazoline Drugs Industry Trends
  2. 2.2 Isoxazoline Drugs Industry Drivers
  3. 2.3 Isoxazoline Drugs Industry Opportunities and Challenges
  4. 2.4 Isoxazoline Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Isoxazoline Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Isoxazoline Drugs Revenue by Region
  3. 3.2.1 Global Isoxazoline Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Isoxazoline Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Isoxazoline Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Isoxazoline Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Isoxazoline Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Isoxazoline Drugs Sales by Region
  9. 3.4.1 Global Isoxazoline Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Isoxazoline Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Isoxazoline Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Isoxazoline Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Isoxazoline Drugs Revenue by Manufacturers
  2. 4.1.1 Global Isoxazoline Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Isoxazoline Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Isoxazoline Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Isoxazoline Drugs Sales by Manufacturers
  6. 4.2.1 Global Isoxazoline Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Isoxazoline Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Isoxazoline Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Isoxazoline Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Isoxazoline Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Isoxazoline Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Isoxazoline Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Isoxazoline Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Isoxazoline Drugs Market CR5 and HHI
  16. 4.8.2 2025 Isoxazoline Drugs Tier 1, Tier 2, and Tier 3
5 Isoxazoline Drugs Market by Type
  1. 5.1 Global Isoxazoline Drugs Revenue by Type
  2. 5.1.1 Global Isoxazoline Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Isoxazoline Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Isoxazoline Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Isoxazoline Drugs Sales by Type
  6. 5.2.1 Global Isoxazoline Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Isoxazoline Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Isoxazoline Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Isoxazoline Drugs Price by Type
6 Isoxazoline Drugs Market by Application
  1. 6.1 Global Isoxazoline Drugs Revenue by Application
  2. 6.1.1 Global Isoxazoline Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Isoxazoline Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Isoxazoline Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Isoxazoline Drugs Sales by Application
  6. 6.2.1 Global Isoxazoline Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Isoxazoline Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Isoxazoline Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Isoxazoline Drugs Price by Application
7 Company Profiles
  1. 7.1 Zoetis Inc
  2. 7.1.1 Zoetis Inc Company Information
  3. 7.1.2 Zoetis Inc Business Overview
  4. 7.1.3 Zoetis Inc Isoxazoline Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Inc Isoxazoline Drugs Product Portfolio
  6. 7.1.5 Zoetis Inc Recent Developments
  7. 7.2 Nissan Chemical Corporation
  8. 7.2.1 Nissan Chemical Corporation Company Information
  9. 7.2.2 Nissan Chemical Corporation Business Overview
  10. 7.2.3 Nissan Chemical Corporation Isoxazoline Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Nissan Chemical Corporation Isoxazoline Drugs Product Portfolio
  12. 7.2.5 Nissan Chemical Corporation Recent Developments
  13. 7.3 Merck Animal Health Inc.
  14. 7.3.1 Merck Animal Health Inc. Company Information
  15. 7.3.2 Merck Animal Health Inc. Business Overview
  16. 7.3.3 Merck Animal Health Inc. Isoxazoline Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Animal Health Inc. Isoxazoline Drugs Product Portfolio
  18. 7.3.5 Merck Animal Health Inc. Recent Developments
  19. 7.4 Elanco Animal Health Incorporated
  20. 7.4.1 Elanco Animal Health Incorporated Company Information
  21. 7.4.2 Elanco Animal Health Incorporated Business Overview
  22. 7.4.3 Elanco Animal Health Incorporated Isoxazoline Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Elanco Animal Health Incorporated Isoxazoline Drugs Product Portfolio
  24. 7.4.5 Elanco Animal Health Incorporated Recent Developments
  25. 7.5 Boehringer Ingelheim International GmbH
  26. 7.5.1 Boehringer Ingelheim International GmbH Company Information
  27. 7.5.2 Boehringer Ingelheim International GmbH Business Overview
  28. 7.5.3 Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Boehringer Ingelheim International GmbH Isoxazoline Drugs Product Portfolio
  30. 7.5.5 Boehringer Ingelheim International GmbH Recent Developments
8 North America
  1. 8.1 North America Isoxazoline Drugs Market Size by Type
  2. 8.1.1 North America Isoxazoline Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Isoxazoline Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Isoxazoline Drugs Price by Type (2021-2032)
  5. 8.2 North America Isoxazoline Drugs Market Size by Application
  6. 8.2.1 North America Isoxazoline Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Isoxazoline Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Isoxazoline Drugs Price by Application (2021-2032)
  9. 8.3 North America Isoxazoline Drugs Market Size by Country
  10. 8.3.1 North America Isoxazoline Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Isoxazoline Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Isoxazoline Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Isoxazoline Drugs Market Size by Type
  2. 9.1.1 Europe Isoxazoline Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Isoxazoline Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Isoxazoline Drugs Price by Type (2021-2032)
  5. 9.2 Europe Isoxazoline Drugs Market Size by Application
  6. 9.2.1 Europe Isoxazoline Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Isoxazoline Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Isoxazoline Drugs Price by Application (2021-2032)
  9. 9.3 Europe Isoxazoline Drugs Market Size by Country
  10. 9.3.1 Europe Isoxazoline Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Isoxazoline Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Isoxazoline Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Isoxazoline Drugs Market Size by Type
  2. 10.1.1 China Isoxazoline Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Isoxazoline Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Isoxazoline Drugs Price by Type (2021-2032)
  5. 10.2 China Isoxazoline Drugs Market Size by Application
  6. 10.2.1 China Isoxazoline Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Isoxazoline Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Isoxazoline Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Isoxazoline Drugs Market Size by Type
  2. 11.1.1 Asia Isoxazoline Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Isoxazoline Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Isoxazoline Drugs Price by Type (2021-2032)
  5. 11.2 Asia Isoxazoline Drugs Market Size by Application
  6. 11.2.1 Asia Isoxazoline Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Isoxazoline Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Isoxazoline Drugs Price by Application (2021-2032)
  9. 11.3 Asia Isoxazoline Drugs Market Size by Country
  10. 11.3.1 Asia Isoxazoline Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Isoxazoline Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Isoxazoline Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Isoxazoline Drugs Market Size by Type
  2. 12.1.1 SAMEA Isoxazoline Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Isoxazoline Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Isoxazoline Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Isoxazoline Drugs Market Size by Application
  6. 12.2.1 SAMEA Isoxazoline Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Isoxazoline Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Isoxazoline Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Isoxazoline Drugs Market Size by Country
  10. 12.3.1 SAMEA Isoxazoline Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Isoxazoline Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Isoxazoline Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Isoxazoline Drugs Value Chain Analysis
  2. 13.1.1 Isoxazoline Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Isoxazoline Drugs Production Mode & Process
  6. 13.2 Isoxazoline Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Isoxazoline Drugs Distributors
  9. 13.2.3 Isoxazoline Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst